do glp 1 The GLP-1 revolution: What UAB researchers are discovering about how these drugs work GLP-1 Receptor Agonists as Treatments

The Stubborn Weight Carrier: Individuals who cannot seem to shift weight from specific problem areas, no matter how much they exercise or restrict calories

GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss

Developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) has been a surprisingly challenging task

The success of these agents in preclinical models and clinical trials suggests a promising future for multiagonists in the treatment of metabolic diseases, with the most recent glucose-dependent insulinotropic peptide receptor:glucagon-like peptide 1 receptor:glucagon receptor (GIPR:GLP-1R:GCGR) triagonists rivaling the efficacy of bariatric surgery

Some insurance plans require prior authorization before approval

Participants Patients with type 2 diabetes